The tech giant is making another move into the health market via a partnership with pharmaceutical company GlaxoSmithKline

Apple has formed a partnership with the British drug company GlaxoSmithKline, in order to conduct a clinical study on rheumatoid arthritis. The three-month study will rely on the iPhone's ResearchKit, a diagnosis tool designed by Apple.

Using the iPhone's sensors GSK will be able to monitor patients' symptoms such as fatigue and joint pain. They will also be prompted to answer health related questions.

The results from this trial will be a determining factor weather the drug company decides to use Apple in the future for other clinical studies. It is also a step further into the medical field for a company that has been trying to break into the health market.

$15 provides access to this article and every case-study, interview, and analysis piece that we publish for the next 30 days. Our Premium Subscription also provides access to a database of over 100,000 articles on innovation in brand, customer, and retail experience.
Already a subscriber? Log in